Related Experiment Video
Updated: Nov 10, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Cardiovascular risk estimation in young patients with ankylosing spondylitis: A new model based on a prospective
Mihaela Ionescu1, Paris Ionescu1, Adrian Paul Suceveanu1
1Department of Clinical Medical Sciences, Faculty of General Medicine, 'Ovidius' University of Constanta, 900527 Constanta, Romania.
Insights
The Systematic Coronary Risk Evaluation (SCORE) chart underestimates cardiovascular disease risk in young ankylosing spondylitis patients. A relative risk (RR) chart, especially with carotid ultrasound, offers better cardiovascular risk prediction in this population.
Area of Science:
- Cardiology
- Rheumatology
- Public Health
Background:
- Cardiovascular (CV) risk assessment is crucial for patient management.
- Standard CV risk charts have limitations in special populations.
- Ankylosing spondylitis (AS) patients may have underestimated CV risk.
Purpose of the Study:
- To evaluate if the Systematic Coronary Risk Evaluation (SCORE) chart underestimates CV risk in young AS patients.
- To highlight the need for improved CV risk assessment models for AS.
- To compare the predictive value of SCORE and a relative risk (RR) chart using carotid plaque detection.
Main Methods:
- Prospective study of 70 Romanian AS patients (≤50 years) without prior CV disease, diabetes, or CKD.
- CV risk assessed using the SCORE chart and an RR chart (smoking, systolic BP, total cholesterol).
- Carotid plaques detected via ultrasound; C-reactive protein (CRP) levels measured.
Main Results:
- Most patients (65.71%) had low SCORE risk; none were high/very high risk.
- Carotid plaques found in 21.74% of low-risk and 50% of moderate-risk SCORE patients.
- ESC guidelines identified 22 patients (31.4%) at high/very high CV risk due to carotid plaques.
- RR chart showed higher plaque prevalence with RR>1.
- CRP >3 mg/dl associated with RR>1.
Conclusions:
- The SCORE system significantly underestimates CV risk in young AS patients, particularly those with carotid plaques.
- The RR chart, enhanced by carotid ultrasound and CRP levels, provides more accurate CV risk prediction in this population.
- New, tailored risk assessment models are necessary for AS patients to prevent CV events.
Abstract:
Cardiovascular (CV) risk assessment charts are useful in establishing a patient therapeutic plan, but the most commonly used charts have essential limitations when applied to special populations. Our aim was to determine whether the Systematic Coronary Risk Evaluation (SCORE) chart underestimates the CV risk in young patients with ankylosing spondylitis (AS) and to promote the necessity of new risk assessment models. We conducted a prospective study in Constanta County, Romania including 70 consecutive patients ≤50 years of age, previously diagnosed with AS, without a history of established CV disease, diabetes mellitus and chronic kidney disease. We estimated the CV risk using SCORE based on total cholesterol, applied for a high-risk population, such as the Romanian population. Estimation of CV risk was also conducted with the relative risk (RR) chart, considering the following variables: Smoking, systolic blood pressure and total cholesterol. The majority of patients (n=46, 65.71%) had low risk according to the SCORE chart and only 24 (34.28%) were found to have moderate CV risk; none of them with high or very high CV risk. Ten patients (21.74%) of the 46 who were considered to have a low risk based on the SCORE system presented with carotid plaques. Twelve patients (50%) of the remaining 24 with moderate CV risk were found to have carotid plaques. According to 2016 'European Society of Cardiology' (ESC) guidelines, 22 of all 70 patients were at high/very high CV risk due to the presence of carotid plaques. Comparing the RR chart with carotid plaque detection, only 4 out of 30 (13.3%) patients with RR=1 had carotid plaques; the frequency was higher in those with RR>1. Our results attested that the SCORE system underestimates the risk in patients with carotid plaques. Carotid ultrasound provided a more heightened sensitivity of the RR chart. C-reactive protein (CRP) >3 mg/dl is associated with RR>1, making this chart a better CV risk predictive system in this particular category of patients.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management
Relative Risk
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

